Atrial septal defect (ASD) is one of the most common types of congenital heart defects, occurring in about 25% of children. An atrial septal defect occurs when there is a failure to close the communication between the right and left atria. It encompasses defects involving both the true septal membrane and other defects that allow for communication between both atria. There are five types of atrial septal defects ranging from most frequent to least: patent foramen ovale, ostium secundum defect, ostium primum defect, sinus venosus defect, and coronary sinus defect. Small atrial septal defects usually spontaneously close in childhood. Large defects that do not close spontaneously may require percutaneous or surgical intervention to prevent further complications such as stroke, dysrhythmias, and pulmonary hypertension.
Though atrial septal defects occur as singular defects, ASDs are associated with Mendelian inheritance, aneuploidy, transcription errors, mutations, and maternal exposures. Atrial septal defects are noted in patients with Down syndrome, Treacher-Collins syndrome, Thrombocytopenia-absent radii syndrome, Turner syndrome, and Noonan syndrome; these syndromes occur as a result of Mendelian inheritance. Maternal exposure to rubella and drugs, such as cocaine and alcohol can also predispose the unborn fetus to develop an ASD. Additionally, ASDs have been associated with familial genetic disorders and conduction defects. Transcription factors important during the atrial septation include GATA4, NKzX2-5, and TBX5. Holt-Oram syndrome ("heart-hand" syndrome) commonly characterized by a congenital heart defect (ASD in 58% of patients or VSD in 28% of patients), dysrhythmias and upper limb malformations usually involving the hands are associated with TBX5 mutations. Mutations in the NKX2-5 gene have been associated with congenital heart disease (ASD and Tetralogy of Fallot), AV blocks, and juvenile sudden cardiac death.
Atrial septal defects occur with other congenital heart defects (i.e., ventricular septal defects). In some patients with congenital heart disease, communication between the left and right heart circulations is crucial for survival. Patients with tricuspid atresia, transposition of the great vessels, variants of hypoplastic left heart syndrome, pulmonic/ tricuspid atresia with hypoplastic right heart, transposition of the great vessels, and total anomalous pulmonary venous return require the alternate blood flow that an ASD provides to survive the primary lesion until a more definitive solution is provided.
The prevalence of congenital heart disease and ASDs has increased over the past 50 years. In the 1930s congenital heart disease was diagnosed in less than 1 per 1000 live births. In recent years, congenital heart disease is diagnosed in 9 per 1000 live births. Atrial septal defects were identified between 1945 and 1949 in less than 0.5 live births per 1000. More recent epidemiologic data suggest that ASDs occur in 1.6 per 1000 live births. The noted increase in prevalence is probably not due to an increase in disease as much as improvements in imaging modalities and training of practitioners. Several factors have been associated with the increased prevalence of congenital heart disease including advanced maternal age. Interestingly, economic and geographical differences have been noted in the diagnosis. Congenital heart disease is diagnosed more commonly in patients in developed countries who have higher incomes.
Atrial septation begins during the fourth week of gestation. Septation begins with the growth of the primary atrial septum (septum primum) from the roof of the primitive atrium caudally towards the endocardial cushions. The caudal end of the septum primum is covered by mesenchymal cells derived from the embryonic endocardium (the mesenchymal cap). As the septum primum grows toward and attaches to the atrioventricular endocardial cushions, it closes and ultimately obliterates the ostium primum (the gap between the mesenchymal cap and the atrioventricular cushions). Once the leading edge of the septum primum attaches anteriorly to the atrioventricular cushions, the primitive atrium is divided into the right and left atria. The septum primum dorsally attaches to the dorsal mesenchymal protrusion. As the ostium primum closes, cell death occurs in the dorsal aspect of the septum primum, forming the ostium secundum. The septum secundum forms from the roof of the atria to the right of the septum primum. As it grows caudally and partially covers the ostium secundum, the space created between the septum primum and the septum secundum creates the foramen ovale. In the fetus, the foramen ovale allows for oxygen rich blood to bypass the lungs by flowing directly from the right atrium to the left atrium. When the child is born and begins to breathe, the change in pulmonary vascular resistance and the resultant decrease in right atrial pressure that occurs allows for the septum primum to close the foramen ovale.
As the patent foramen ovale is a subclass of the ostium secundum defect, it is not a defect of the "true septum." The patent foramen ovale is the most common septal anomaly and occurs when ends the septum primum, and the septum secundum do not approximate and close the foramen ovale after the child breathes its first breath. The 4 types of atrial septal defects are:
Normally, the pressure in the right atrium is significantly lower than the left atrium; therefore, blood flows from the left atrium to the right atrium causing a left-to-right shunt. The size of the defect determines how significant the shunt is. Significant shunts have a ratio of pulmonary (Qp) to systemic flow (Qs) that is greater than 1.5:1 (Qp/Qs > 1.5). Chronic volume overload due to high pulmonary blood flow causes remodeling of the pulmonary vasculature. As pulmonary vessels remodel, the layer of smooth muscle increases in the vascular wall. Because the muscle layer in the vascular wall increases, resistance to flow in the pulmonary circuit increases. Due to the increased vascular resistance and pulmonary pressures increase, and pulmonary hypertension develops. Once pulmonary pressures equal systemic pressures, the shunt across the ASD reverses, and deoxygenated blood flows into the left atrium and systemically. When the reversal of the shunt across an ASD occurs due to pulmonary hypertension, a condition known as Eisenmenger syndrome develops.
Atrial septal defects are frequently asymptomatic. The characteristic murmur is a soft, systolic ejection murmur over the pulmonic area (second intercostal space) combined with a wide, fixed splitting of S2. Many ASDs go undiagnosed until adulthood; therefore, treatment, especially of large defects, is often delayed. Untreated large defects can cause exercise intolerance, cardiac dysrhythmias, palpitations, increased incidence of pneumonia, pulmonary hypertension and increased mortality. Eisenmenger syndrome is a rare, but severe complication of untreated ASDs due to vascular remodeling caused by chronic over flow (through a left-to-right shunt). As the vascular resistance increases right atrial pressures approach systemic. When right atrial pressures exceed systemic pressures, there is a reversal of shunt flow. Clinically Eisenmenger syndrome patients develop chronic cyanosis, increased pulmonary vascular resistance, dyspnea on exertion, syncope, and increased susceptibility to infection.
Patients with smaller heart defects (less than 5 mm) might not develop any symptomology while patients with defects ranging between 5 to 10 mm will present in the fourth or fifth decade of life. Patients with larger defects present sooner, in the third decade of life. Patients may present with dyspnea, fatigue, exercise intolerance, palpitations or signs of right-sided heart failure. Approximately 20% of adult patients develop atrial tachydysrhythmias preoperatively. Evidence of stroke or transient ischemic attack especially following the diagnosis of a peripheral blood clot should raise suspicions for an ASD.
Diagnostic imaging is important in determining the size of the defect and is crucial in determining treatment options. A transthoracic echocardiogram is the gold standard imaging modality. A transthoracic echocardiogram allows one to detect the size of the defect, understand the direction of blood flow, find associated abnormalities (involvement of the endocardial cushions and atrial-ventricular valves), examine the heart for structure and function, estimate pulmonary artery pressure, and estimate the pulmonary/systemic flow ratio (Qp/Qs). A transesophageal echocardiogram is a better tool for diagnosing the rarer cardiac defects.
Though echocardiography is the gold standard for evaluation of ASDs, other diagnostic modalities include cardiac CT and MRI. Both CT and MRI examine structures surrounding the heart and in the thoracic cavity. Chest x-ray findings are not as helpful diagnostically, though the chest x-ray assists providers to monitor clinical status by identifying cardiomegaly and pulmonary artery enlargement. Exercise testing can help determine the reversibility of shunt flow and the response of patients with pulmonary artery hypertension to activity. Cardiac catheterization is contraindicated in patients who are young and present with small, uncomplicated ASDs.
Patients with atrial septal defects less than 5 mm in size frequently experience spontaneous closure of the defect in the first year of life. Defects that are greater than 1cm will most likely require medical/surgical intervention to close the defect. Patients presenting with atrial dysrhythmias initially require control of the abnormal rhythm and anticoagulation; definitive intervention can occur once the team gains control of the dysrhythmia. Monitoring adult patients with small defects and no signs of right heart failure is appropriate. An echocardiography every 2 to 3 years evaluates right heart function and structure. History of TIA or stroke requires more aggressive monitoring and possibly surgical intervention.
If an ASD requires closure, options include percutaneous and surgical intervention. Indications for treatment include stroke, a hemodynamically significant shunt greater than 1.5:1 and evidence of systemic oxygen desaturation. Percutaneous transcatheter closure poses less risk for the patient, but it is only useful for the closure of ostium secundum defects. Percutaneous transcatheter ASD closure has a post-procedural complication risk of 7.2% compared to a post-surgical complication risk of 24%. Complications associated with percutaneous closure risk include arrhythmias, AV blocks, cardiac erosion and thromboembolism. Contraindications to percutaneous closure are: small hemodynamically insignificant ASDs, ostium primum defects, sinus venosus defects and coronary sinus defects, and secundum defects with advanced pulmonary hypertension. When atrial septal defects are closed percutaneously, patients require antiplatelet therapy for the subsequent 6 months. Women with large ASDs and Eisenmenger syndrome should avoid pregnancy due to the risks of aggravating pulmonary artery hypertension that might be present and the increased occurrence of dysrhythmias. Surgical closure of atrial septal defects requires the placement of a patch over the lesion through an incision in the right atrium.
In conclusion, atrial septal defects are common congenital heart defects and can range from clinically asymptomatic lesions to lesions that cause pulmonary hypertension, systemic cyanosis and vascular complications such as strokes. Most small defects will spontaneously close in the first year of life; however, large defects associated with significant systemic to pulmonary shunts and systemic oxygen desaturation require percutaneous of surgical intervention.
Improving healthcare team outcomes in patients with atrial septal defects requires an interprofessional team with strong input from the patient's primary care physician. Adults and children with atrial septal defects require consistent follow up with cardiologists to monitor the heart structure, heart function, and the patient's hemodynamic status. When a patient requires intervention, cardiac interventionists and thoracic surgeons with experience caring for children and adults with congenital heart disease provide the best outcomes for patients with congenital heart disease. Monitoring with echocardiograms assesses the functional health of the heart and right heart function. Dysrhythmias require aggressive control. Pregnancy is not advised for women with large ASDs and pulmonary hypertension.
|||Meissner I,Whisnant JP,Khandheria BK,Spittell PC,O'Fallon WM,Pascoe RD,Enriquez-Sarano M,Seward JB,Covalt JL,Sicks JD,Wiebers DO, Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clinic proceedings. 1999 Sep [PubMed PMID: 10488786]|
|||Celermajer DS, Atrial septal defects: even simple congenital heart diseases can be complicated. European heart journal. 2018 Mar 21 [PubMed PMID: 29194471]|
|||Aoki H,Horie M, Electrical disorders in atrial septal defect: genetics and heritability. Journal of thoracic disease. 2018 Sep [PubMed PMID: 30305944]|
|||Torres AJ, Hemodynamic assessment of atrial septal defects. Journal of thoracic disease. 2018 Sep [PubMed PMID: 30305948]|
|||Chelu RG,Horowitz M,Sucha D,Kardys I,Ingremeau D,Vasanawala S,Nieman K,Paul JF,Hsiao A, Evaluation of atrial septal defects with 4D flow MRI-multilevel and inter-reader reproducibility for quantification of shunt severity. Magma (New York, N.Y.). 2018 Aug 31 [PubMed PMID: 30171383]|
|||van der Linde D,Konings EE,Slager MA,Witsenburg M,Helbing WA,Takkenberg JJ,Roos-Hesselink JW, Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. Journal of the American College of Cardiology. 2011 Nov 15 [PubMed PMID: 22078432]|
|||Kloesel B,DiNardo JA,Body SC, Cardiac Embryology and Molecular Mechanisms of Congenital Heart Disease: A Primer for Anesthesiologists. Anesthesia and analgesia. 2016 Sep [PubMed PMID: 27541719]|
|||Naqvi N,McCarthy KP,Ho SY, Anatomy of the atrial septum and interatrial communications. Journal of thoracic disease. 2018 Sep [PubMed PMID: 30305943]|
|||Naik RJ,Shah NC, Teenage heart murmurs. Pediatric clinics of North America. 2014 Feb [PubMed PMID: 24267454]|
|||El-Segaier M,Pesonen E,Lukkarinen S,Peters K,Ingemansson J,Sörnmo L,Sepponen R, Atrial septal defect: a diagnostic approach. Medical [PubMed PMID: 16941100]|
|||Neema PK, Eisenmenger syndrome: an unsolved malady. Annals of cardiac anaesthesia. 2012 Oct-Dec [PubMed PMID: 23041681]|
|||Martin SS,Shapiro EP,Mukherjee M, Atrial septal defects - clinical manifestations, echo assessment, and intervention. Clinical Medicine Insights. Cardiology. 2014 [PubMed PMID: 25861226]|
|||Behjati-Ardakani M,Golshan M,Akhavan-Karbasi S,Hosseini SM,Behjati-Ardakani MA,Sarebanhassanabadi M, The Clinical Course of Patients With Atrial Septal Defects. Iranian journal of pediatrics. 2016 Aug [PubMed PMID: 27713810]|
|||Warnes CA,Williams RG,Bashore TM,Child JS,Connolly HM,Dearani JA,Del Nido P,Fasules JW,Graham TP Jr,Hijazi ZM,Hunt SA,King ME,Landzberg MJ,Miner PD,Radford MJ,Walsh EP,Webb GD, ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation. 2008 Dec 2 [PubMed PMID: 18997168]|
|||Yang MC,Wu JR, Recent review of transcatheter closure of atrial septal defect. The Kaohsiung journal of medical sciences. 2018 Jul [PubMed PMID: 30063008]|